NAMPT inhibition reduces macrophage inflammation through the NAD+/PARP1 pathway to attenuate liver ischemia–reperfusion injury
Jiao Lu, Menghao Wang, Yu‐Cheng Chen, Hua Song, Diguang Wen, Jianfei Tu, Yuan Guo, Zuojin Liu
Topics & Concepts
Nicotinamide phosphoribosyltransferaseNAD+ kinaseNicotinamide adenine dinucleotideInflammationPARP1Liver injuryReperfusion injuryDownregulation and upregulationNicotinamidePharmacologyTUNEL assayBiologyPoly ADP ribose polymeraseCancer researchMedicineChemistryApoptosisIschemiaBiochemistryImmunologyInternal medicineEnzymeGenePolymeraseSirtuins and Resveratrol in MedicinePARP inhibition in cancer therapyBiochemical and Molecular Research